Keyword: Watson Pharaceuticals

The Securities and Exchange Commission has nabbed another set of traders who allegedly profited off biopharma secrets. This time, their alleged source wasn't a pharma insider, but a former FDA official.

China's CSPC has inked an outlicense deal worth $106 million with Allergan unit Watson for an unspecified complex generic drug.